Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Verneris

Showing results (11-20 of 201) with videos related to

Pageof 21
Sort By:
British Journal of Haematology|November 10, 2022
Can allogeneic haematopoietic cell transplantation be curative in classical Crohn's disease?Laura McLaughlin, Edwin DeZoeten, Michael R Verneris
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2010
Acquisition, preparation, and functional assessment of human NK cells for adoptive immunotherapyDean A Lee, Michael R Verneris, Dario Campana
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2010
Killing the killer: natural killer cells to treat Ewing's sarcomaYong-Oon Ahn, Brenda Weigel, Michael R Verneris
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2016
Erratum to: "Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction" [Biol Blood Marrow Transplant 2016;22:1159-1166]Lucie M Turcotte, Ashley Yingst, Michael R Verneris
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2016
Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune DysfunctionLucie M Turcotte, Ashley Yingst, Michael R Verneris
Best Practice & Research. Clinical Haematology|September 16, 2008
Use of natural killer cells as immunotherapy for leukaemiaBartosz Grzywacz, Jeffrey S Miller, Michael R Verneris
Pediatric Blood & Cancer|July 29, 2011
Treatment of relapsed acute lymphoblastic leukemia: approaches used by pediatric oncologists and bone marrow transplant physiciansMichael J Burke, Bruce Lindgen, Michael R Verneris
Journal of Clinical Immunology|June 25, 2002
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and miceMichael R Verneris, Jeanette Baker, Matthias Edinger, et al.
Cancer Journal (Sudbury, Mass.)|November 21, 2015
Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against CancerZachary B Davis, Martin Felices, Michael R Verneris, et al.
Seminars in Immunology|March 13, 2014
Clinical utility of natural killer cells in cancer therapy and transplantationDavid A Knorr, Veronika Bachanova, Michael R Verneris, et al.
Pageof 21

Showing results (11-20 of 201) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|November 10, 2022
Can allogeneic haematopoietic cell transplantation be curative in classical Crohn's disease?Laura McLaughlin, Edwin DeZoeten, Michael R Verneris
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2010
Acquisition, preparation, and functional assessment of human NK cells for adoptive immunotherapyDean A Lee, Michael R Verneris, Dario Campana
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2010
Killing the killer: natural killer cells to treat Ewing's sarcomaYong-Oon Ahn, Brenda Weigel, Michael R Verneris
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2016
Erratum to: "Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction" [Biol Blood Marrow Transplant 2016;22:1159-1166]Lucie M Turcotte, Ashley Yingst, Michael R Verneris
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2016
Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune DysfunctionLucie M Turcotte, Ashley Yingst, Michael R Verneris
Best Practice & Research. Clinical Haematology|September 16, 2008
Use of natural killer cells as immunotherapy for leukaemiaBartosz Grzywacz, Jeffrey S Miller, Michael R Verneris
Pediatric Blood & Cancer|July 29, 2011
Treatment of relapsed acute lymphoblastic leukemia: approaches used by pediatric oncologists and bone marrow transplant physiciansMichael J Burke, Bruce Lindgen, Michael R Verneris
Journal of Clinical Immunology|June 25, 2002
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and miceMichael R Verneris, Jeanette Baker, Matthias Edinger, et al.
Cancer Journal (Sudbury, Mass.)|November 21, 2015
Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against CancerZachary B Davis, Martin Felices, Michael R Verneris, et al.
Seminars in Immunology|March 13, 2014
Clinical utility of natural killer cells in cancer therapy and transplantationDavid A Knorr, Veronika Bachanova, Michael R Verneris, et al.
Pageof 21